PharmaCyte Biotech to Attend 53rd Annual Meeting of the American Society of Clinical Oncology
May 31, 2017 13:34 pm UTC| Business
LAGUNA HILLS, Calif., May 31, 2017 -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes using its signature live-cell...
PharmaCyte Biotech to Attend 53rd Annual Meeting of the American Society of Clinical Oncology
May 31, 2017 13:34 pm UTC| Business
LAGUNA HILLS, Calif., May 31, 2017 -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes using its signature live-cell...
PharmaCyte Biotech to Attend 53rd Annual Meeting of the American Society of Clinical Oncology
May 31, 2017 13:34 pm UTC| Business
LAGUNA HILLS, Calif., May 31, 2017 -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes using its signature live-cell...
PharmaCyte Biotech to Attend 53rd Annual Meeting of the American Society of Clinical Oncology
May 31, 2017 13:34 pm UTC| Business
LAGUNA HILLS, Calif., May 31, 2017 -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes using its signature live-cell...
PharmaCyte Biotech to Attend 53rd Annual Meeting of the American Society of Clinical Oncology
May 31, 2017 13:34 pm UTC| Business
LAGUNA HILLS, Calif., May 31, 2017 -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes using its signature live-cell...
PharmaCyte Biotech to Attend 53rd Annual Meeting of the American Society of Clinical Oncology
May 31, 2017 13:34 pm UTC| Business
LAGUNA HILLS, Calif., May 31, 2017 -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes using its signature live-cell...
PharmaCyte Biotech to Attend 53rd Annual Meeting of the American Society of Clinical Oncology
May 31, 2017 13:34 pm UTC| Business
LAGUNA HILLS, Calif., May 31, 2017 -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted therapies for cancer and diabetes using its signature live-cell...
South Africa’s plan to move away from coal: 8 steps to make it succeed
Germany lowers voting age to 16 for the European elections
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects